⚠ AI Risk Brief Interpretation layer — deterministic data below

ResMed tightened regulatory compliance disclosures and added manufacturing quality standards risk; one equity risk removed.

Direction ↑ More concerning

ThemesRegulatory & Legal Supply Chain Workforce & Talent

Classification is based on semantic text similarity scoring and may include approximations. “No match” means no high-confidence textual match was found — not necessarily that a section was removed.

🟢 New in Current Filing Disclosure change7/10

RESMED INC. AND SUBSIDIARIES

ITEM 1A RISK FACTORS…

Read full text

ITEM 1A RISK FACTORS

Before deciding to purchase, hold or sell our common stock, you should carefully consider the risks described below in addition to the other cautionary statements and risks described elsewhere, and the other information contained, in this Report and in our other filings with the SEC, including our subsequent reports on Forms 10-Q and 8-K. The risks and uncertainties described below are not the only ones we face. Additional risks and uncertainties not presently known to us or that we currently deem immaterial may also affect our business. If any of these known or unknown risks or uncertainties actually occurs with material adverse effects on us, our business, financial condition and results of operations could be seriously harmed. In that event, the market price for our common stock will likely decline, and you may lose all or part of your investment.

🟢 New in Current Filing RESMED INC. AND SUBSIDIARIES 🔒

🔴 No Match in Current Filing Risks Related to the Securities Markets and Ownership of Our Common Stock 🔒

And 18 more changes in the full comparison.

21 changes in this historical filing

The complete historical comparison (2023 vs 2022) is available on the Pro plan.

Get Pro access Already a Pro subscriber? View full diff →